Below are 10 news articles from the past 7 days regarding COVID-19 to help guide you in making your decision. Using your best judgement, take into consideration only the articles that are most relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Articles that are from know reputable sources have been flagged with "Trusted: True".

Article 1 of 10
Title: Rates of COVID-19, influenza on the rise in Manitoba: Report
Publisher: CTV News Winnipeg
Trusted: False
Posted: Today
COVID-19 and flu cases are rising in Manitoba, with 312 new COVID-19 cases detected in the past week and a rise in coronavirus activity in Brandon and Winnipeg. The positivity rate is at 28.2%, with an average of 220 daily tests. There have been 78 hospital admissions, 12 ICU admissions, and one death from COVID-19 this week. Influenza A cases have nearly doubled, with 70 new cases this week, bringing the total to 156 since July. Wastewater surveillance data and the Provincial Respiratory Surveillance Report indicate that COVID detection rates are increasing. With rising cases and hospitalizations, the trend suggests a potential increase in COVID-19 hospitalizations in the coming weeks.

Article 2 of 10
Title: Athletes, Vaccines and Cardiac Deaths
Publisher: Office for Science and Society
Trusted: False
Posted: 1 day ago
The article discusses the myth that COVID-19 vaccines are causing sudden cardiac deaths in young athletes and provides evidence to refute this claim. Here are the key points and important facts to help forecast COVID-19 hospitalizations: 1. The article references a study published in the journal Circulation, which analyzed data on sudden cardiac death in young athletes over a 20-year period. This comprehensive review involved examining records from the NCAA, insurance claims, and dedicated cardiac databases. 2. During the 20-year period, there were 1,102 deaths among the student athletes studied, with sudden cardiac death accounting for 143 cases. This demonstrates that sudden death among athletes is rare. 3. The incidence of sudden cardiac death among athletes has decreased over the past 20 years, and there was no spike in cases after the introduction of COVID-19 vaccines. This contradicts the claim that the vaccines are causing sudden cardiac deaths in young athletes. 4. The study found that accidents, suicide, and homicide were the leading causes of death among young athletes, not sudden cardiac arrest. 5. Out of the 143 sudden cardiac death cases, only eight involved myocarditis (inflammation of the heart muscle), and all but one case occurred before the pandemic. This refutes the notion that COVID-19 vaccines are causing myocarditis-related deaths in young athletes. 6. The presence of defibrillators at sports facilities and public events is credited for saving lives, as timely defibrillation can prevent fatal cardiac arrests. The case of NFL player Damar Hamlin, who suffered a cardiac arrest during a game, highlights the importance of rapid intervention. 7. While pre-participation screening for athletes is controversial, some believe it contributes to the decreasing trend in sudden cardiac deaths. However, there is disagreement on the best approach for screening, and the NCAA in the U.S. does not mandate routine electrocardiograms (ECGs). 8. Young men and black athletes are at higher risk of sudden cardiac death compared to young women and white athletes. Basketball players had the highest risk among all sports. 9. The article concludes that competitive sports can lead to sudden death in individuals with undiagnosed cardiac issues, but the rates of such deaths are going down, not up, and COVID-19 vaccines are not implicated. Overall, this article provides evidence-based information to refute the myth that COVID-19 vaccines are causing sudden cardiac deaths in young athletes. The data presented can help inform forecasting models for COVID-19 hospitalizations by providing reassurance that vaccine-related complications among young athletes are extremely rare.

Article 3 of 10
Title: COVID-19: Peterborough area risk index remains high; 2 outbreaks at PRHC - Peterborough
Publisher: Global News Toronto
Trusted: False
Posted: 2 days ago
The article reports that the community risk index for COVID-19 in the Peterborough, Ont., region has remained high for the fourth consecutive week. The region includes Peterborough, Peterborough County, Curve Lake First Nation, and Hiawatha First Nation. Key indicators such as case rates, PCR test positivity, and wastewater surveillance are at varying levels. The BA.2.86 variant has been confirmed in the region. As of November 22, there were 113 active PCR lab-confirmed cases, with 155 deaths since the pandemic began. Hospitalizations as of November 20 stood at 29 inpatients with COVID-19 at the Peterborough Regional Health Centre. Vaccination rates show that approximately 82% of area residents have received two doses of a COVID-19 vaccine. The article also details active outbreaks in various facilities in the region.

Article 4 of 10
Title: COVID-19 Vaccine: What You Need to Know
Publisher: Johns Hopkins Medicine
Trusted: True
Posted: 3 days ago
The article discusses the importance of the COVID-19 vaccine in preventing serious illness, hospitalization, and death. It highlights that vaccines are updated to combat the evolving virus strains, with the 2023-2024 vaccine targeting the XBB.1.5 variant. The updated vaccine is effective against current variants causing COVID-19 cases in the U.S. Recommendations include one shot for most individuals, with exceptions for certain groups like immunocompromised individuals and young children. Side effects are typically mild and short-lived. The vaccine is recommended for pregnant individuals and children, with guidance on timing for those previously infected or vaccinated. Natural immunity is not superior to vaccine-induced immunity. The article emphasizes the safety and effectiveness of COVID-19 vaccines approved by the FDA and encourages getting vaccinated at pharmacies or other convenient locations.

Article 5 of 10
Title: COVID-19 levels remain high in Ottawa, public health agency reports
Publisher: Ottawa Citizen
Trusted: False
Posted: 3 days ago

Article 6 of 10
Title: Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study
Publisher: The Lancet
Trusted: False
Posted: 3 days ago

Article 7 of 10
Title: N.B. COVID-19 death toll increases by 4, child under 4 hospitalized
Publisher: CBC.ca
Trusted: False
Posted: 4 days ago
COVID-19 hospitalizations in New Brunswick seem to be decreasing, with 44 hospitalizations and 3 ICU admissions between November 5 and November 11, down from 52 hospitalizations and 4 ICU admissions in the previous report. The province's Respiratory Watch report indicates that COVID-19 activity remains moderate, with all indicators stable. However, it's important to note that the province has changed its definition of COVID-19 deaths, only counting those who die in the hospital since September. There have been 11 new COVID-19 outbreaks declared, with 5 in nursing homes. The health networks, Horizon and Vitalité, are updating their COVID-19 reports with Horizon showing a decrease in hospitalizations and an increase in healthcare workers testing positive. Additionally, there have been 3 new flu cases confirmed during this period, bringing the seasonal total to 21. The Department of Health encourages people to get their flu shots, with 142,938 people having received theirs since October 4.

Article 8 of 10
Title: Mayo Clinic Q and A: Who should get the latest COVID-19 vaccine?
Publisher: Mayo Clinic
Trusted: False
Posted: 4 days ago
The CDC recommends the 2023-2024 COVID-19 mRNA vaccine for everyone aged 6 months and older. While the vaccine is especially beneficial for those at high risk, including the elderly, immunocompromised, young children, and those with chronic conditions, even healthy young individuals should consider it to protect themselves and those around them. The updated vaccine targets the highly transmissible XBB.1.5 strain and is the only approved COVID-19 vaccine currently available. Getting vaccinated, practicing good health habits, and taking precautions in crowded spaces can help reduce the risk of infection and severe illness.

Article 9 of 10
Title: Nova Scotia reports 35 COVID-19 deaths since August 2023
Publisher: CBC.ca
Trusted: False
Posted: 4 days ago
The recent Nova Scotia Respiratory Watch report reveals 35 COVID-19 deaths since August 27, 2023, indicating a decrease compared to the same period in 2022, which saw over 40 deaths. The report, covering Nov. 5 to Nov. 11, also highlights zero influenza deaths for the 2023-24 season so far. It mentions five new outbreaks in long-term care facilities, including one influenza, four COVID-19, and one RSV outbreak. This data suggests a positive trend in managing COVID-19 hospitalizations and highlights the ongoing monitoring of respiratory illnesses in Nova Scotia.

Article 10 of 10
Title: Outlook of pandemic preparedness in a post-COVID-19 world
Publisher: Nature.com
Trusted: False
Posted: 5 days ago
The article emphasizes the importance of comprehensive pandemic preparedness, including early-stage research and development (R&D) and robust surveillance systems. Here's a summary along with some important facts to help forecast COVID-19 hospitalizations: Lesson 1: Prioritize early-stage R&D and platform technologies: Early-stage research and platform technologies, such as mRNA and adenovirus platforms, played a crucial role in the rapid development and authorization of COVID-19 vaccines. The speed and flexibility of vaccine platforms contributed to reducing morbidity and mortality, eventually lowering the reliance on non-pharmaceutical interventions (NPIs) to slow disease spread. Basic and translational research, as well as investments in flexible vaccine development platforms, are key to a swift response to the next pandemic. Initiatives like those by the US National Institute of Allergy and Infectious Diseases (NIAID) and the Coalition for Epidemic Preparedness Innovations (CEPI) aim to advance understanding and develop vaccines for various virus families. Agile vaccine technologies, such as mRNA platforms, will be critical for future pandemic responses due to the unpredictability of emerging pathogens. Efforts are also underway to apply mRNA technology beyond COVID-19, including for influenza and other endemic pathogens. Lesson 2: Bolster pandemic pathogen intelligence: Expanding and leveraging surveillance systems, such as the Global Influenza Surveillance and Response System (GISRS), is crucial for early detection and response to infectious disease outbreaks in real time. Strengthening and expanding surveillance systems globally, including in more than 70 countries without WHO-designated influenza surveillance centers, is necessary. Investments in laboratory infrastructure, diagnostic capabilities, and workforce development at local, national, and international levels are needed for effective surveillance. Sharing pathogen data is essential for effective response to newly detected outbreaks. The WHO's Pandemic Influenza Preparedness (PIP) Framework facilitates data sharing and equitable access to vaccines. An optimal disease intelligence system would aim to predict the next pandemic pathogen using existing data, predictive modeling, and artificial intelligence. A gradient-based warning system for pandemics, similar to early warning systems in healthcare and weather forecasting, could initiate appropriate responses at different levels of threat. The evolution of disease surveillance and intelligence systems requires major investment, coordination, and cooperation across global, national, and local levels, with strong leadership from global health actors. Forecasting COVID-19 Hospitalizations: Surveillance systems and early warning mechanisms can help forecast COVID-19 hospitalizations by detecting and monitoring the spread of the virus. By tracking factors such as infection rates, hospitalization rates, and variant prevalence, public health officials can make informed predictions about future hospitalization needs. For example, if a new, highly transmissible variant is detected in a community with low vaccination rates, public health officials can anticipate a potential surge in hospitalizations and plan accordingly. Additionally, real-time data on hospitalization rates can help identify areas with high COVID-19 activity, allowing for targeted interventions to prevent further spread and reduce the burden on healthcare systems. In conclusion, comprehensive pandemic preparedness, including early-stage R&D and robust surveillance systems, is key to effectively responding to future pandemics. The lessons learned from COVID-19 highlight the importance of agility, collaboration, and data sharing in pandemic response efforts. By prioritizing these areas and utilizing tools such as early warning systems, we can improve our ability to forecast and manage COVID-19 hospitalizations and future pandemic threats.